Stay updated with breaking news from Sight Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sight Sciences, Inc. (NASDAQ:SGHT – Get Free Report) major shareholder D1 Capital Partners L.P. sold 2,852,036 shares of the stock in a transaction dated Wednesday, December 27th. The shares were sold at an average price of $5.86, for a total transaction of $16,712,930.96. Following the completion of the sale, the insider now owns 3,000,000 shares […]
Decision ensures continued access to comprehensive outflow procedure enabled by OMNI® Surgical System technology for glaucoma patients...
Sight Sciences (NASDAQ:SGHT – Get Free Report) and Medite Cancer Diagnostics (OTCMKTS:MDIT – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Profitability This table compares Sight Sciences and […]
Sight Sciences (NASDAQ:SGHT – Get Free Report) and Medite Cancer Diagnostics (OTCMKTS:MDIT – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk. Valuation & Earnings This table compares Sight […]
MENLO PARK, Calif., Dec. 18, 2023 -- Sight Sciences, Inc. , an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve...